SHINE's final SER for Wisconsin facility issued by NRC

March 1, 2023, 12:00PMNuclear News
SHINE’s isotope production building, called the Chrysalis, under construction in October 2022. (Photo: SHINE)

The Nuclear Regulatory Commission has issued its final safety evaluation report (SER) related to the operating license application for SHINE Technologies' large-scale medical isotope production facility, known as The Chrysalis, in Janesville, Wis. The SER documents the results of NRC staff’s technical and safety review of SHINE’s application. SHINE announced the NRC’s decision on February 27.

A record of decision concerning the proposed issuance of the operating license will be published by the NRC at a future date.

To continue reading, log in or create a free account!

Related Articles

NRC unveils Part 53 final rule

March 26, 2026, 7:01AMNuclear News

The Nuclear Regulatory Commission has finalized its new regulatory framework for advanced reactors that officials believe will accelerate, simplify, and reduce burdens in the new reactor...